Loading...
ROCO
4123
Market cap845mUSD
Nov 12, Last price  
35.85TWD
Name

Center Laboratories Inc

Chart & Performance

D1W1MN
ROCO:4123 chart
P/E
—
P/S
16.35
EPS
—
Div Yield, %
3.99%
Shrs. gr., 5y
3.92%
Rev. gr., 5y
2.39%
Revenues
1.62b
+16.06%
253,578,000299,710,000364,519,000462,221,000569,032,000684,436,000713,740,000741,934,000898,759,0006,792,238,00015,039,831,00019,391,814,00021,648,222,0001,437,674,000717,045,000500,107,000767,722,0001,394,008,0001,617,869,000
Net income
-1.10b
L+10.88%
15,344,000114,653,00045,461,000138,407,00012,964,00042,556,00099,852,00051,911,000333,262,000421,502,00019,455,000249,998,0006,083,797,000-203,589,0003,786,465,0001,816,180,000-575,621,000-995,421,000-1,103,683,000
CFO
416m
P
38,810,00067,712,00044,856,00039,114,000-3,861,00070,113,00016,230,00041,504,000-7,539,000-138,291,0001,155,652,0002,013,704,000617,838,000-286,450,000-269,565,000-358,137,000-189,878,000-963,438,000415,715,000
Dividend
Aug 02, 20241.43061 TWD/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only
Add note

Profile

Center Laboratories, Inc. engages in the manufacture and trading of various medicines in Taiwan. It engages in the research and development of small molecule drugs; manufacture and sale of pharmaceuticals; development of proteins and antibodies; and pharmaceutical CDMO, medical device, nutritional health and agribiotechnology, stem cell and immune cell therapy, and industry investment fund and venture capital businesses. The company was founded in 1959 and is headquartered in Taipei, Taiwan.
URL
https://www.centerlab.com.tw/
IPO date
Dec 18, 2002
Employees
Domiciled in
TW
Incorporated in
TW

Valuation

Title
TWD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT